Trial to control the formation of endolymphatic hydrops from the viewpoint of the water homeostasis of the inner ear

被引:0
作者
Takeda, Taizo [1 ]
Takeda, Setsuko
Kakigi, Akinobu [2 ]
机构
[1] Kochi Med Sch, Dept Otolaryngol, Nankoku, Kochi, Japan
[2] Kobe Univ, Grad Sch Med, Dept Otolaryngol Head & Neck Surg, 7-5-1 Kusunokicho Chuo Ku, Kobe, Hyogo 6500017, Japan
关键词
Meniere's disease; Vasopressin; Copeptin; Lithium; Vaptan; Osmotic diuretics; NONPEPTIDE V-2 ANTAGONIST; PITUITARY-ADRENAL AXIS; ANTIDIURETIC-HORMONE; MENIERES-DISEASE; REBOUND PHENOMENON; LITHIUM TREATMENT; OPC-31260; OSMOLALITY; ISOSORBIDE; RHYTHMS;
D O I
10.1016/j.anl.2025.01.001
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Endolymphatic hydrops, which is one of the pathologic features of Me<acute accent>nie`re's disease, has been experimentally and clinically confirmed to be influenced by the blood circulation of vasopressin (VP). It is widely acknowledged that VP plays a pivotal role in regulating water homeostasis. It should also be noted that VP is susceptible to a number of external factors, including changes in the environment, dehydration, and fluctuations in atmospheric pressure. Furthermore, VP is a key regulator of the hypothalamic-pituitary-adrenal (HPA) axis. The HPA axis is a significant neuroendocrine system that plays a role in regulating responses to emotional and physical stress, as well as the sleep/wake cycle (circadian rhythm). It seems that VP is changeable via the HPA axis. It may be beneficial to consider pharmacological normalization of VP as a potential approach to controlling Me<acute accent>nie`re's disease. Nevertheless, measuring 8-Arg-vasopressin (AVP), the most prevalent variant of VP, poses certain challenges for a number of reasons. Copeptin is co-released with AVP, is relatively stable in the posterior pituitary as well as in blood plasma, and is increasingly being used as an AVP surrogate in clinical diagnostics. It is thought that the use of copeptin as a marker for AVP may help to clarify the clinical features of Me<acute accent>nie`re's disease. In this review, we will consider trials to control the formation of endolymphatic hydrops from the viewpoint of the vasopressin-aquaporin 2 system. Furthermore, we will explore reports on clinical treatment, pharmacological agents, and future prospects.
引用
收藏
页码:137 / 140
页数:4
相关论文
共 54 条
  • [21] Circadian rhythms in the hypothalamo-pituitary-adrenal (HPA) axis
    Kalsbeek, A.
    van der Spek, R.
    Lei, J.
    Endert, E.
    Buijs, R. M.
    Fliers, E.
    [J]. MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2012, 349 (01) : 20 - 29
  • [22] EXPERIMENTAL-STUDY ON MENIERES-DISEASE
    KITAHARA, M
    TAKEDA, T
    YAZAWA, Y
    MATSUBARA, H
    KITANO, H
    [J]. OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 1982, 90 (04) : 470 - 481
  • [23] Meniere's Attacks Occur in the Inner Ear with Excessive Vasopressin Type-2 Receptors
    Kitahara, T.
    Doi, K.
    Maekawa, C.
    Kizawa, K.
    Horii, A.
    Kubo, T.
    Kiyama, H.
    [J]. JOURNAL OF NEUROENDOCRINOLOGY, 2008, 20 (12) : 1295 - 1300
  • [25] V1a vasopressin receptors maintain normal blood pressure by regulating circulating blood volume and baroreflex sensitivity
    Koshimizu, Taka-aki
    Nasa, Yoshihisa
    Tanoue, Akito
    Oikawa, Ryo
    Kawahara, Yuji
    Kiyono, Yasushi
    Adachi, Tetsuya
    Tanaka, Toshiki
    Kuwaki, Tomoyuki
    Mori, Toyoki
    Takeo, Satoshi
    Okamura, Hitoshi
    Tsujimoto, Gozoh
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (20) : 7807 - 7812
  • [26] MOLECULAR NANOTUBE AGGREGATES OF BETA-CYCLODEXTRINS AND GAMMA-CYCLODEXTRINS LINKED BY DIPHENYLHEXATRIENES
    LI, G
    MCGOWN, LB
    [J]. SCIENCE, 1994, 264 (5156) : 249 - 251
  • [27] Lutz EG, 1974, J Med Soc New Jersey, V71, P502
  • [28] MATSUBARA H, 1985, ACTA OTO-LARYNGOL, P115
  • [29] A review of the nonpressor and nonantidiuretic actions of the hormone vasopressin
    Mavani, Gaurang P.
    DeVita, Maria V.
    Michelis, Michael F.
    [J]. FRONTIERS IN MEDICINE, 2015, 2 : 19
  • [30] Water may cure patients with Meniere disease
    Naganuma, Hideaki
    Kawahara, Katsumasa
    Tokumasu, Koji
    Okamoto, Makito
    [J]. LARYNGOSCOPE, 2006, 116 (08) : 1455 - 1460